Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-214366
Filing Date
2023-08-16
Accepted
2023-08-16 16:50:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d503035ddefa14a.htm DEFA14A 18850
2 GRAPHIC g503035dsp002.jpg GRAPHIC 438029
3 GRAPHIC g503035dsp003.jpg GRAPHIC 533865
  Complete submission text file 0001193125-23-214366.txt   1358872
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36066 | Film No.: 231178796
SIC: 2834 Pharmaceutical Preparations